A peptide fragment derived from the C-terminal region of growth hormone, studied in research involving lipid metabolism and adipose tissue signaling pathways. It is commonly used in laboratory models examining fat metabolism without affecting IGF-1 or insulin sensitivity.
AOD-9604 is a peptide fragment derived from the C-terminal region of human growth hormone. In research settings, it is studied for its relationship to lipid metabolism and fat-processing pathways, particularly within models examining how specific growth hormone fragments interact with metabolic signaling systems.
AOD-9604 is studied for activity associated with lipolytic and anti-lipogenic signaling pathways linked to the hGH 176–191 region. In laboratory research, it is used to examine how this peptide fragment influences fat metabolism, adipose-related signaling, and broader metabolic pathway activity without representing the full biological profile of intact human growth hormone. It is commonly used in studies involving lipid metabolism, adipocyte signaling, metabolic regulation, and growth hormone fragment biology.
AOD-9604 emerged from research investigating which regions of human growth hormone were associated with metabolic activity. Early studies focused on the C-terminal fragment as a distinct research target, leading to further investigation of AOD-9604 in preclinical and clinical models examining fat metabolism and related signaling behavior.
For research use only. Not for human or veterinary use. Detailed storage guidelines →